维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

16篇 您的检索式：作者名="ACOSTA EP"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Pharmacokineties of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women显示文摘	Acosta EP Bardeguez A Zorrilla CD	2004	Antimierob Agents Chemother2004，48，：	1
	2	Determination of appropriate dosing of influenza drugs in pediatric patients显示文摘	Acosta EP Kimberlin DW		0，，05：	1
	3	Oseltamivir dosing for influ- enza infection in premature neonates 显示文摘	Acosta EP Jester P Gal P	2010	J Infect Dis2010，202，4：	1
	4	Ganciclovir popula- tion pharmacokinetics in neonates following intravenous admin- istration of ganciclovir and oral administration of a liquid val- ganciclovir formulation 显示文摘	Acosta EP Brundage RC King JR	2007	Clin Pharmacol Ther2007，81，6：	1
	5	Antiretroviral pharmacokinetics in the paecliatric population: a review显示文摘	King JR Kimberlin DW Aldrovandi GM Acosta EP	2002	Clin Pharmacokinet2002，41，：	1
	6	Ganciclovir Population Pharmacokinetics in Neonates Following Intravenous Administration of Ganciclovir and Oral Administration of a Liquid Valganciclovir Formulation显示文摘	Acosta EP Brundage RC King JR	2007	Clin Pharmacol Ther2007，8，2：	1
	7	Tipranavir: a novel nonpeptidic protease inhibit- or of HIV显示文摘	King JR Acosta EP	2006	Clin Pharmacokinet2006，45，7：	1
	8	Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease显示文摘	Kimberlin DW Acosta EP Sánchez PJ		0，，06：	1
	9	Intra- cellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy 显示文摘	Moore JD Acosta EP Johnson VA	2007	Antivir Ther2007，12，6：	1
	10	Long-term stability of nelfinavir mesylate in human plasma显示文摘	urner ML Acosta EP	2000	Clin Chem2000，46，12：	1
	11	Adher- ence-resistance relationships for protease and non-nucleo- side reverse transcriptase inhibitors explained by virological fitness 显示文摘	BANGSBERG DR ACOSTA EP GUPTA R	2006	AIDS2006，20，2：	1
	12	Concentration-controlled zidovudine therapy显示文摘	Fletcher CV Acosta EP Henry K	1998	Clin Pharmacol Ther1998，64，3：	1
	13	Adherence resist ance relationships for protease and non-nucleoside reverse tran scriptase inhibitors explained by virological fitness 显示文摘	Bangsberg DR Acosta EP Gupta R	2006	AIDS2006，20，2：	1
	14	Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women显示文摘	ACOSTA EP BARDEGUEZ A ZORRILLA CD	2004	Antimicrob Agents Chemother2004，48，2：	1
	15	Pharmacodynam- ics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug sus- ceptibility and adherence 显示文摘	Wu H Huang Y Acosta EP	2006	J Pharmacokinet Phar- macodyn2006，33，4：	1
	16	Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease 显示文摘	Kimberlin D Acosta EP Sanehez P	2008	Infect Dis2008，197，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费